Expression, purification and characterisation of recombinant Escherichia coli derived chicken interleukin-12 |
| |
| Authors: | Thomas Jesse D Morris Kirsten R Godfrey Dale I Lowenthal John W Bean Andrew G D |
| |
| Institution: | CSIRO - Australian Animal Health Laboratories, Livestock Industries, Private Bag 24, Geelong, Victoria 3220, Australia. |
| |
| Abstract: | Zoonotic viruses, such as H5N1 Avian Influenza, pose major threats to both animals and humans, and with this in mind there is a need for the development of new anti-viral strategies. The cytokine interleukin-12 (IL-12) is known to play a pivotal regulatory role in the anti-viral response due to its role in the induction of the key anti-viral cytokine IFN-gamma. Therefore, strategies which provide a means for the production of therapeutic quantities of IL-12 may be of major benefit. Here we describe the development of biologically active Escherichia coli (E. coli) derived chicken IL-12 (ChIL-12). The single chain ChIL-12 gene was cloned into the pET32b expression vector, transformed into the BL-21 E. coli strain and expression induced with IPTG. Over expressed protein was solubilised with zwittergent detergent and isolated utilising Nickel ion affinity chromatography. Biological activity was determined as ChIL-12 stimulated proliferation of pre-treated T-cells in vitro. This study is the first example of a biologically active E. coli derived IL-12 from a non-mammalian vertebrate subsequently providing a means for testing the anti-viral therapeutic potential of ChIL-12 in an in vivo model. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
